Penicillin

Lore & Background

rubens. Fleming's student Cecil George Paine was the first to successfully use penicillin to treat eye infection (neonatal conjunctivitis) in 1930.

Reader's Guide

Penicillins are a foundational class of antibiotics that revolutionized the treatment of bacterial infections. Their discovery and development marked a turning point in medicine, enabling effective therapy for previously deadly infections such as streptococcal meningitis. Over time, semisynthetic penicillins were developed to broaden the antimicrobial spectrum, including antistaphylococcal, aminopenicillin, and antipseudomonal groups. Despite widespread use and the emergence of bacterial resistance, penicillins remain clinically important. In the United States, about 10% of the population claims penicillin allergies, but most can eventually tolerate it, and cross-reactivity with cephalosporins is low. The unit system for prescribing penicillin, originally necessary due to impure mixtures, is now largely obsolete outside the US.

Did You Know?

• Eight species of Penicillium, in the section Chrysogena, produce penicillins.
• Penicillin G is given intramuscularly or intravenously; penicillin V is given by mouth.

The Discovery and the Oxford Breakthrough

In 1928, Scottish physician Alexander Fleming identified a crude extract of the mould Penicillium rubens that would reshape medicine. Though the finding was modest at first, its implications grew rapidly. In 1930, Fleming's student Cecil George Paine became the first person to apply penicillin therapeutically, treating a case of neonatal conjunctivitis. The real breakthrough came in 1940, when a team at the University of Oxford led by Howard Florey and Ernst Boris Chain succeeded in isolating the purified compound, which they designated penicillin F. With a stable, concentrated form finally available, Fleming himself administered purified penicillin to a patient suffering from streptococcal meningitis in 1942, marking the drug's first major clinical application. The collective achievement of these three men was recognized in 1945, when Chain, Fleming, and Florey jointly received the Nobel Prize in Physiology or Medicine. Their work transformed penicillin from a curious laboratory observation into a life-saving treatment for bacterial infections.

Culturing the Mould: Production and the Rise of Semisynthetics

Penicillins are naturally produced by eight species of Penicillium within the section Chrysogena, with P. chrysogenum and P. rubens being the principal contributors. In modern pharmaceutical practice, the vast majority of clinically used penicillins are manufactured through deep tank fermentation of P. chrysogenum, followed by purification. The specific product obtained depends heavily on the culture medium: the well-known Peoria strain of P. chrysogenum yields penicillin G as its main component when grown in corn steep liquor, whereas introducing phenoxyethanol or phenoxyacetic acid shifts production toward penicillin V. Of all the natural penicillins discovered, only two purified compounds have reached routine clinical use—penicillin G for intramuscular or intravenous administration and penicillin V for oral dosing. Beyond these naturals, the compound 6-aminopenicillanic acid, derived by stripping the side chains from penicillin G, serves as a versatile precursor. From 6-APA, chemists have built three families of semisynthetic penicillins—antistaphylococcal, broad-spectrum aminopenicillins, and antipseudomonal agents—each extending the antibiotic's reach against a wider array of bacterial pathogens.

A Double-Edged Sword: Efficacy, Allergy, and Resistance

Penicillins earned their place in medicine as some of the earliest drugs capable of defeating infections caused by staphylococci and streptococci, and they remain widely prescribed for a broad range of bacterial conditions. Yet their very success has bred complications. Extensive and prolonged use has driven many bacterial species to develop resistance, narrowing the spectrum of organisms that still respond to treatment. On the patient side, roughly one in ten Americans reports a penicillin allergy. However, the data suggest that this claim is often overstated: positive skin-test results decline by about ten percent for every year a patient avoids the drug, meaning approximately ninety percent of those who initially react can eventually tolerate penicillin without issue. Furthermore, individuals with confirmed penicillin sensitivity can generally still use cephalosporins, another class of β-lactam antibiotics, because the immunoglobulin E cross-reactivity between the two groups is only around three percent. These facts underscore that penicillin's legacy is one of both extraordinary therapeutic power and the ongoing challenges of resistance and perceived intolerance.

Naming a Molecule: Nomenclature, Chemistry, and the Quirk of Units

Alexander Fleming coined the word 'penicillin' on 7 March 1929, choosing it to avoid the cumbersome phrase 'mould broth filtrate' in his paper for the British Journal of Experimental Pathology. He explained in his 1945 Nobel lecture that he simply followed orthodox naming conventions, deriving the term from the genus Penicillium much as 'digitalin' came from the plant Digitalis. In contemporary usage, the term has broadened to encompass any β-lactam antimicrobial bearing a thiazolidine ring fused to the β-lactam core, whether or not it is a natural product. Fleming's original P. rubens strain produced penicillin F—named in his honour—but this compound proved unstable, difficult to isolate, and yielded in only small quantities. The unit system for prescribing penicillin, once necessary because early preparations were ill-defined mixtures whose potency varied from batch to batch, is now largely obsolete outside the United States. One unit of penicillin G sodium equals 0.600 micrograms, while one unit of penicillin V potassium equals 0.625 micrograms. In the 1940s, a standard vial of 5,000 Oxford units might contain anywhere from 15 to 20 milligrams of active material, a variability that made weight-based dosing impractical at the time.